Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - rotigotine - patch - 18 mg/40 cm2

Malta - English - Malta Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - piribedil - prolonged-release tablet - piribedil 50 mg - anti-parkinson drugs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim ltd - pergolide - tablet - neurological agent - horses

United Kingdom - English - VMD (Veterinary Medicines Directorate)

forum animal health limited - apomorphine hydrochloride - solution for injection - neurological agent - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

domes pharma sc - apomorphine - solution for injection - emetic - dogs

European Union - English - EMA (European Medicines Agency)

ucb pharma s.a.   - rotigotine - restless legs syndrome; parkinson disease - anti-parkinson drugs - leganto is indicated for the symptomatic treatment of moderate to severe idiopathic restless-legs syndrome in adults.leganto is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson’s disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or ‘on-off’ fluctuations).

European Union - English - EMA (European Medicines Agency)

ucb pharma s.a. - rotigotine - restless legs syndrome; parkinson disease - anti-parkinson drugs - parkinson's disease: neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or 'on-off' fluctuations).restless-legs syndrome: neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless-legs syndrome in adults.

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - pergolide mesilate - tablet - 1 milligram(s) - pergolide - non food-producing horses - neurological preparations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - cabergoline - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - cabergoline - oral tablet - 1mg